Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients
Links shared publicly online about this topic.
- 1,829total visits
Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients
Array biopharma inc. announced yesterday positive top-line data from a phase 1 clinical trial in patients with type 2 diabetes with its novel small molecule glucokinase activator (gka), arry-403.
View full resource at medicalnewstoday.com
Tags: Diabetes, Type 2 Diabetes, Phase 1 Clinical Trial, Clinical Trial
Most Recently Shared on August 12, 2009 at 10:50 am By:
Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients: Array Bi.. http://bit.ly/IvFWt
Advertisement
